GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make ...

GSK posted a better-than-expected fourth quarter on Wednesday and lifted its 2031 sales target to nearly $50 billion as the British drugmaker aims to invest heavily in its specialty medicines to ...

GSK has today posted a better-than-expected fourth quarter and lifted its 2031 sales target to nearly $50 billion as the ...

When ready to release a new chart version or add a new chart, copy the chart directory from the source repository into the charts/ directory. Make sure the chart directory is named after the actual ...

“After four years of weakness, we have strong leadership at the helm again, and I really look forward to working with President Trump, Vice President Vance, and their team to truly Make America Great ...

In the week ending Jan. 10, flu positivity testing was up 20% in California. The report shows moderate RSV activity and low COVID-19 activity in the same period. Norovirus, which causes sudden ...

New tuberculosis regimens and a vaccine for RSV. These and other major medical ... treatments but also the nation’s place at the helm of biomedical innovation. “The importance of NIAID cannot ...

Respiratory syncytial virus (RSV) causes cold-like symptoms in most people but can cause more serious problems in some, especially babies and older adults. Almost all children get RSV at least once by ...

The trifecta of flu, COVID-19 and RSV is bad enough, but this year throw in other lesser but still consequential bugs, including norovirus. What can you do? Wash your hands, then wash them again later ...

Cases of influenza, RSV, COVID-19 and norovirus are surging at the same time Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in Billboard and Reader's Digest.

President-elect Donald Trump has nominated a remarkably unqualified person, Tulsi Gabbard, to be the director of National Intelligence. The Senate should reject her nomination, but also strengthen ...